GPCR News and Research

RSS
Existing drugs could help prevent deadly familial stomach and lobular breast cancers

Existing drugs could help prevent deadly familial stomach and lobular breast cancers

Scientists identify promising new therapeutic target for prostate cancer

Scientists identify promising new therapeutic target for prostate cancer

Heptares Therapeutics announces recipients of Malcolm Campbell Memorial Prize for 2015

Heptares Therapeutics announces recipients of Malcolm Campbell Memorial Prize for 2015

Heptares Therapeutics, AstraZeneca report significant progress in drug discovery collaboration

Heptares Therapeutics, AstraZeneca report significant progress in drug discovery collaboration

TriStar² S multi-label microplate reader now available with monochromator technology

TriStar² S multi-label microplate reader now available with monochromator technology

New international consortium to advance GPCR research for drug development

New international consortium to advance GPCR research for drug development

Internal water channels can pave way for novel approaches in drug development

Internal water channels can pave way for novel approaches in drug development

Trevena's Phase 1b data for TRV130 published in the journal Pain

Trevena's Phase 1b data for TRV130 published in the journal Pain

P2Y12 and blood clotting: an interview with Dr. Jacobson, NIH

P2Y12 and blood clotting: an interview with Dr. Jacobson, NIH

The future of high throughput screening: an interview with Mark Wigglesworth, Director High Throughput Screening, AstraZeneca

The future of high throughput screening: an interview with Mark Wigglesworth, Director High Throughput Screening, AstraZeneca

Understanding GPCRs and controlling inflammation: an interview with Dr. Richard Proia, NIDDK, NIH

Understanding GPCRs and controlling inflammation: an interview with Dr. Richard Proia, NIDDK, NIH

RuiYi declares $15M Series B financing to advance monoclonal antibodies targeting GPCR receptors

RuiYi declares $15M Series B financing to advance monoclonal antibodies targeting GPCR receptors

Two new risk loci for bipolar disorder identified

Two new risk loci for bipolar disorder identified

Monash University research offers new hope to people with heart attacks

Monash University research offers new hope to people with heart attacks

Photoreactive compounds open new routes to treatment of neurological diseases

Photoreactive compounds open new routes to treatment of neurological diseases

Domain Therapeutics, XOMA to jointly evaluate DTect-All to identify allosteric modulator antibodies

Domain Therapeutics, XOMA to jointly evaluate DTect-All to identify allosteric modulator antibodies

Trevena prices initial public offering of common stock

Trevena prices initial public offering of common stock

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure

Unprecedented, atom-scale simulation of G protein-coupled receptor site's transformation

Unprecedented, atom-scale simulation of G protein-coupled receptor site's transformation

Heptares starts HTL9936 Phase 1 study for improving cognitive function in Alzheimer's patients

Heptares starts HTL9936 Phase 1 study for improving cognitive function in Alzheimer's patients